Poland· PL-100501267

Ixchiq

A medicinal product containing szczepionka przeciw chikungunya (żywa), registered in Poland by Valneva Austria GmbH.

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedIxchiqATC—REGISTER NO.PL-100501267PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Szczepionka przeciw Chikungunya (żywa)
Manufacturer
Valneva Austria GmbH
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    09120040710460

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c9360e22-884d-436f-a343-225ea9280d63
GET /v1/drugs/c9360e22-884d-436f-a343-225ea9280d63?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
  "source": "urpl",
  "strength": "-",
  "packaging": "Rp ¦ EU/1/24/1828/001 ¦ 157207\n1 fiol.  proszku ¦ 1 amp.-strzyk. 0,5 ml rozpuszczalnika\n¦ UR/Z/4c/082/25 - 09120040710460",
  "substance": "Wirus Chikungunya (CHIKV), szczep Δ5nsP3 (żywy, atenuowany) nie mniej niż 3,0 log10 TCID50",
  "common_name": "Szczepionka przeciw Chikungunya (żywa)",
  "pl_product_id": "100501267",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about szczepionka przeciw chikungunya (żywa).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.